1. INTRODUCTION
1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Market Segmentation
1.5. Currency
1.6. Assumptions
1.7. Base and Forecast Years Timeline
1.8. Key Benefits for the Stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Design
2.2. Research Process
3. EXECUTIVE SUMMARY
3.1. Key Findings
3.2. Analyst View
4. MARKET DYNAMICS
4.1. Market Drivers
4.2. Market Restraints
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Supplier
4.3.2. Bargaining Power of Buyers
4.3.3. The Threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis
5. GLOBAL POULTRY VACCINE MARKET BY DISEASE TYPE
5.1. Introduction
5.2. Avian Influenza
5.3. Marek’s Diseases
5.4. Bronchitis
5.5. Others
6. GLOBAL POULTRY VACCINE MARKET BY PRODUCT
6.1. Introduction
6.2. Inactivated Vaccines
6.3. Attenuated Live Vaccines
6.4. Recombinant Vaccines
6.5. Others
7. GLOBAL POULTRY VACCINE MARKET BY GEOGRAPHY
7.1. Introduction
7.2. North America
7.2.1. United States
7.2.2. Canada
7.2.3. Mexico
7.3. South America
7.3.1. Brazil
7.3.2. Argentina
7.3.3. Others
7.4. Europe
7.4.1. UK
7.4.2. Germany
7.4.3. France
7.4.4. Italy
7.4.5. Others
7.5. Middle East and Africa
7.5.1. Saudi Arabia
7.5.2. Israel
7.5.3. Others
7.6. Asia Pacific
7.6.1. Japan
7.6.2. China
7.6.3. India
7.6.4. South Korea
7.6.5. Indonesia
7.6.6. Thailand
7.6.7. Others
8. COMPETITIVE ENVIRONMENT AND ANALYSIS
8.1. Major Players and Strategy Analysis
8.2. Market Share Analysis
8.3. Mergers, Acquisitions, Agreements, and Collaborations
8.4. Competitive Dashboard
9. COMPANY PROFILES
9.1. Zoetis Inc.
9.2. Boehringer Ingelheim International GmbH
9.3. Ceva Santé Animale
9.4. Merck & Co. Inc. (Merck Animal Health)
9.5. AniCon Labor GmbH
9.6. Hester Biosciences Limited
9.7. Elanco Animal Health Incorporated
9.8. Biovac S.A.
9.9. Phibro Animal Health Corporation
9.10. Salfarm Danmark A/S